Faegre Drinker advised Boston Scientific, and Latham & Watkins advised Relievant MedSystems on the deal. Boston Scientific Corporation (NYSE: BSX) announced it has entered into a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised RealBlocks on the financing. RealBlocks announced a $10 million extension of its Series A financing, bringing its total investment amount to $20.7...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represents Figure in the financing. Figure has announced the close of a $70 million Series A funding round. The round is led by...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented ApiJect Holdings in the transaction. ApiJect Holdings, Inc., the parent company of ApiJect Systems, Corp., a medical technology public-benefit corporation transforming...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented ZenBusiness in the transaction. ZenBusiness, the only one-stop guided platform tailored for the entrepreneur’s journey to launch, run, and grow a successful business,...
You must be a Standard 1 Year member to access this content.
